ArticleFrontiers in pharmacology2022

Second-Generation Long-Acting Injectable Antipsychotics and the Risk of Treatment Failure in a Population-Based Cohort.

Donica Janzen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.